XBiotech Inc. (NASDAQ: XBIT) Stock Information | RedChip

XBiotech Inc. (NASDAQ: XBIT) Listen to this Section


$6.31
+0.0700 ( +1.12% ) 27.4K

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Market Data


Open


$6.31

Previous close


$6.24

Volume


27.4K

Market cap


$194.05M

Day range


$6.15 - $6.45

52 week range


$3.51 - $9.96

Insider Ownership Transactions

Total Amount Purchased: 2,320,355.00 | $ 14,641,440.05

Date Type Amount Purchased Purchaser
2024-06-21 Sale -37500.00 Libby Peter
2024-06-21 Sale -37500.00 MacAdam Donald H.
2024-06-21 Sale -37500.00 Waldin Jan-Paul
2024-06-21 Sale -37500.00 MCKENZIE W THORPE
2024-01-05 Buy 2470355.00 SIMARD JOHN

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 44 Aug 12, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 13 Jun 20, 2024
10-q Quarterly Reports 44 May 10, 2024
10-k/a Quarterly Reports 18 May 01, 2024
ars Annual reports 1 May 01, 2024
def Proxies and info statements 5 May 01, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.